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In process lung SNP(single nucleotide polymorphism) targeting stud-
ies, we knew that JAK-STAT signaling pathway is responsible for 
several apoptotic and cell cycle regulatory proteins. The family of Jak 
kinases is composed from at least four non-receptor kinases(Tyk2, 
Jak1, Jak2, Jak3). In generally, Jak3 is related lymphoid development, 
immune function and innate genetic disease. But, Jak3 is not well 
deﬁned SNP studies of promoter region in lung cancer.
Therefore, we investigated whether SNPs of Jak3 promoter are 
associated with Korean lung cancer patients. We analyzed 5 SNP 
points(-1514, -866, -672, 64 and 227) of Jak3 promoter by using the 
genomic DNA from 320 Korea lung cancer patients and 268 healthy 
controls. Genotyping was performed by the SNP-IT, SNapShot assay 
and Restriction Fragment Length Polymorphism (RFLP). The allele 
frequencies of each SNP between lung cancer patients and controls 
were estimated by the chi-square tests and odds rations (OR) with 95% 
conﬁdence interval (95% CI). We explored the association between 
SNP points and histopathological factors of the lung cancer patients. 
Also, using these 5 SNPs, linkage disequilibrium and haplotype pat-
terns were examined. 
To these 5 SNP points, -672 point was associated with lung cancer 
risks. In case of -672 SNP point, subgroup analysis of clinicopathologic 
parameters in cancer group showed signiﬁcant differences in male, 
non-smoker and non-drinker. In vitro assay, transfection of A549, 
H1666, Calu1 and H1299 NSCLC cell lines with luciferase reporter 
constructs containing 769 bp of the -672 point(-672 G/A) showed dif-
ference luciferase activity expression patterns.
In conclusion, we conﬁrmed a relation between the Jak3 gene poly-
morphisms and signiﬁcant increased risk in certain subgroup of lung 
cancer patients. SNPs of Korean lung cancer patient in Jak3 promoter 
are related to clinicopathologic parameters in male, non-smoker and 
non-drinker.
In this study, we investigated to single nucleotide polymorphisms 
(SNPs) in the JAK3 and the relationships between the SNPs and the 
risk of lung cancer occurrence in Korean lung cancer patients compared 
to normal controls. This is the ﬁrst study to provide evidence for an as-
sociation of JAK3 gene polymorphisms with lung cancer risk.
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Background: Our previous studies have proved that nm23-H1 gene 
was a tumor metastatic suppressive gene, tumor metastasis phenotype 
of human lung cancer could be reversed by transfection of nm23-H1 
cDNA, but the molecular mechanism of nm23-H1 for inhibiting tumor 
invasion and metastasis is unclear. The aim of this study is to explore the 
molecular mechanism of nm23-H1 reversing the invasion and metastasis 
phenotype in human high-metastatic large cell lung cancer line L9981. 
Methods: The cell growth and the invasive ability were detected in 
L9981 (the primary lung cancer cell line), L9981-pLXSN (the lung 
cancer cell line transfected with vector) and L9981-nm23-H1 (the lung 
cancer cell line transfected with nm23-H1) by MTT assay and modiﬁed 
Boyden chamber, respectively. The mRNA and protein expression of β-
Ccatenin, E-Cadherin, CD44S, CD44V6, MMP-2, TIMP-1, VEGF were 
detected in the same three lung cancer cell lines by RT-PCR and Western 
blot. The change of gene expression and signal transduction were deter-
mined before and after transfection of nm23-H1 gene by microassay. 
Results: Cell proliferation, clone formation and invasive ability in the 
L9981-nm23-H1 lung cancer cell line transfected with nm23-H1 gene 
were signiﬁcantly lower than those in L9981 and L9981-pLXSN lung 
cancer cell lines(P<0.001).No Signiﬁcant difference of cell prolifera-
tion, clone formation and invasive ability was observed between in 
L9981 and L9981- pLXSN lung cancer cell line(P<0.05). The mRNA 
and protein expression of β-Ccatenin, E-Cadherin, TIMP-1 were sig-
niﬁcantly up-regulated in L9981- nm23-H1 lung cancer cell line trans-
fected with nm23-H1 cDNA than those in L9981 and L9981-pLXSN 
lung cancer cell lines (P<0.001), but no signiﬁcant difference of mRNA 
and protein expression of β-Catenin, E-Cadherin and TIMP-1 existed 
between L9981 and L9981-pLXSN lung cancer cell line(P<0.05). The 
mRNA and protein expression of MMP-2, CD446V and VEGF were 
signiﬁcantly down-regulated in the L9981-nm23-H1 lung cancer cell 
line than those in L9981 and L9981-pLXSN lung cancer cell lines 
(P<0.001), but no signiﬁcant difference of mRNA and protein expres-
sion of MMP-2, CD446V and VEGF existed between L9981 and 
L9981-pLXSN lung cancer cell line(P>0.05). 24 gene related to metas-
tasis were upregulated and 34 gene related to metastasis were down-
regulated after transfection of nm23-H1 gene. 36 genes related to signal 
pathway were up-regulated and 29 genes related to signal pathway 
were down-regulated after transfection of nm23-H1 gene. 
Conclusions: (1) nm23-H1 might be a key regulatory gene of metastsis 
related genes and it may play an important role in the Lung Cancer 
Metastatic Suppressive Cascde. (2) nm23-H1 gene can reverse the 
invasive and metastasis phenotype of human high-metastatic large cell 
pulmonary carcinoma cell line L9981 through regulation of the expres-
sion of metastatic genes and signal transduction pathway.
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